The House Ways and Means Committee heard several testimonies on proposals to lower drug prices in the U.S., according to Regulatory Focus.
Pharmacy
Imerys Talc America, which supplies talc for Johnson & Johnson's baby powder, filed for Chapter 11 bankruptcy Feb. 13, according to Bloomberg.
The World Health Organization is warning patients, physicians and pharmacies about a fake cancer drug that is circulating in the U.S. and Europe, according to The Guardian.
Mylan launched its generic version of GlaxoSmithKline's asthma treatment Advair at a price 70 percent lower than the branded treatment, according to Reuters.
After several years of declining revenues, top generic drug maker Teva Pharmaceuticals will turn to high-priced biotech medications in an effort to jumpstart growth, The Wall Street Journal reports.
Advertisement
A federal judge has ruled that AbbVie must turn over documents in a lawsuit that accuses the drugmaker of using "unclean hands" to create a thicket of patents to protect its best-selling drug Humira from competition, according to STAT.
Ahead of the 2020 presidential race, New Jersey Democrat Sen. Cory Booker is working to shed his reputation of being a friend of the pharmaceutical industry, STAT reports.
Johnson & Johnson will shell out $3.4 billion in cash to buy robotic surgery company Auris Health, CNBC reports.
CVS Health has unveiled three redesigned health-focused concept stores in the Houston market, according to CNBC.
The U.S. Securities and Exchange Commission told Johnson & Johnson it can choose not to hold a shareholder vote on a proposal that would send all shareholder disputes to private arbitration hearings rather than federal court, according to The Wall…